naloxonazine has been researched along with n-methylnaloxone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lattanzi, R; Melchiorri, P; Negri, L; Tabacco, F | 1 |
| Franck, J; Lindholm, S; Raaschou, P | 1 |
| Gutkowska, J; Jankowski, M; Mukaddam-Daher, S; Schiller, PW | 1 |
3 other study(ies) available for naloxonazine and n-methylnaloxone
| Article | Year |
|---|---|
Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
Topics: Analgesia; Animals; Blood Pressure; Hypercapnia; Injections, Intravenous; Injections, Intraventricular; Injections, Subcutaneous; Male; Naloxone; Narcotic Antagonists; Oligopeptides; Prosencephalon; Pulmonary Ventilation; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Opioid, mu; Ritanserin; Serotonin Antagonists; Tidal Volume | 1998 |
Modulation of volitional ethanol intake in the rat by central delta-opioid receptors.
Topics: Alcohol Drinking; Animals; Enkephalin, Leucine; Male; Naloxone; Narcotic Antagonists; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 1998 |
The cardiovascular and renal effects of the potent and highly selective mu opioid agonist [Dmt1]DALDA.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Enzyme Inhibitors; Female; Gene Expression; Heart Rate; Hemodynamics; Homeostasis; Kidney; Myocardium; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Vasopressins | 2004 |